Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2013-03-15)Premium Content

Vertex Pharmaceuticals Inc (VRTX)

2013-05-22@10:19:55 ET
Australia Patent for 'Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease' Ceases (ABW)

2013-05-22@05:30:16 ET
Form 144: Filing to Sell 750000 Shares of Vertex Pharmaceuticals Inc (VRTX) (VKR)

2013-05-22@05:11:36 ET
Form 144: Filing to Sell 60000 Shares of Vertex Pharmaceuticals Inc (VRTX) (VKR)

2013-05-22@03:28:00 ET
Australia Patent for 'Triazoles useful as inhibitors of protein kinases' Ceases (ABW)

2013-05-21@17:40:52 ET
After Yesterday's Rally of 2.70% Shares Could Potentially Pullback (PSM)

2013-05-21@17:40:22 ET
Vertex Pharmaceuticals Rises 2.70% on Heavy Volume: Watch For Potential Pullback (PSM)

2013-05-21@08:57:05 ET
Form 4: Update Filing for Vertex Pharmaceuticals Inc (VRTX) (VKR)

2013-05-21@07:26:54 ET
Australia Patent: Vertex Pharmaceuticals Files Application for 'Heteroaryl derivatives as CFTR modulators' (ABW)

2013-05-21@07:23:30 ET
Australia Patent: Vertex Pharmaceuticals Files Application for 'Processes for producing cycloalkylcarboxamido-pyridine benzoic acids' (ABW)

2013-05-21@06:04:27 ET
Australia Patent: Vertex Pharmaceuticals Files Application for 'Modulators of ATP-Binding Cassette transporters' (ABW)

2013-05-21@05:28:56 ET
Form 144: Filing to Sell 602 Shares of Vertex Pharmaceuticals Inc (VRTX) (VKR)

2013-05-21@05:02:00 ET
Form 144: Filing to Sell 609 Shares of Vertex Pharmaceuticals Inc (VRTX) (VKR)

2013-05-20@17:42:19 ET
74.7% Return Seen to Date on SmarTrend Vertex Pharmaceuticals Call (VRTX) (PSM)

2013-05-20@13:15:28 ET
Shares of Vertex Pharmaceuticals Under Pressure, Down 1.9% (F77)

2013-05-20@12:16:22 ET
Vertex Pharmaceuticals Incorporated to redeem USD400m convertible senior subordinated notes (MTO)